title: Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo.
abstract: During the outbreak of SARS in 2002/3, a prototype virus was isolated from a patient in Frankfurt/Germany (strain Frankfurt-1). As opposed to all other SARS-Coronavirus strains, Frankfurt-1 has a 45-nucleotide deletion in the transmembrane domain of its ORF 7b protein. When over-expressed in HEK 293 cells, the full-length protein but not the variant with the deletion caused interferon beta induction and cleavage of procaspase 3. To study the role of ORF 7b in the context of virus replication, we cloned a full genome cDNA copy of Frankfurt-1 in a bacterial artificial chromosome downstream of a T7 RNA polymerase promoter. Transfection of capped RNA transcribed from this construct yielded infectious virus that was indistinguishable from the original virus isolate. The presumed Frankfurt-1 ancestor with an intact ORF 7b was reconstructed. In CaCo-2 and HUH7 cells, but not in Vero cells, the variant carrying the ORF 7b deletion had a replicative advantage against the parental virus (4- and 6-fold increase of virus RNA in supernatant, respectively). This effect was neither associated with changes in the induction or secretion of type I interferon, nor with altered induction of apoptosis in cell culture. However, pretreatment of cells with interferon beta caused the deleted virus to replicate to higher titers than the parental strain (3.4-fold in Vero cells, 7.9-fold in CaCo-2 cells). In Syrian Golden Hamsters inoculated intranasally with 10e4 plaque forming units of either virus, mean titers of infectious virus and viral RNA in the lungs after 24 h were increased 23- and 94.8-fold, respectively, with the deleted virus. This difference could explain earlier observations of enhanced virulence of Frankfurt-1 in Hamsters as compared to other SARS-Coronavirus reference strains and identifies the SARS-CoV 7b protein as an attenuating factor with the SARS-Coronavirus genome. Because attenuation was focused on the early phase of infection in-vivo, ORF 7b might have contributed to the delayed accumulation of virus in patients that was suggested to have limited the spread of the SARS epidemic.
authors.affiliation: Clinical Virology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. pfefferle@bni-hamburg.de
authors.forename: Susanne
authors.initials: S
authors.lastname: Pfefferle
authors.forename: Verena
authors.initials: V
authors.lastname: Krähling
authors.forename: Vanessa
authors.initials: V
authors.lastname: Ditt
authors.forename: Klaus
authors.initials: K
authors.lastname: Grywna
authors.forename: Elke
authors.initials: E
authors.lastname: Mühlberger
authors.forename: Christian
authors.initials: C
authors.lastname: Drosten
mesh_terms: D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D022202:Chromosomes, Artificial, Bacterial; D006224:Cricetinae; D005822:Genetic Vectors; D006801:Humans; D008168:Lung / Q000821:virology; D008647:Mesocricetus; D008969:Molecular Sequence Data; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics* / Q000472:pathogenicity*; D017422:Sequence Analysis, DNA; D017384:Sequence Deletion; D045169:Severe Acute Respiratory Syndrome / Q000473:pathology / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000502:physiology*; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication
chemical_list: C515314:ORF7b protein, SARS coronavirus; D014764:Viral Proteins; D037521:Virulence Factors
references.citation: Curr Top Microbiol Immunol. 2005;287:161-97
references.pmid: 15609512
references.citation: Emerg Infect Dis. 2006 Dec;12(12):1834-40
references.pmid: 17326933
references.citation: Virus Res. 2008 Apr;133(1):101-12
references.pmid: 17451827
references.citation: Virology. 2003 Mar 30;308(1):13-22
references.pmid: 12706086
references.citation: Avian Pathol. 2005 Dec;34(6):439-48
references.pmid: 16537157
references.citation: J Virol. 2002 Nov;76(22):11518-29
references.pmid: 12388713
references.citation: Virol J. 2006 Aug 31;3:63
references.pmid: 16945126
references.citation: Science. 2003 May 30;300(5624):1394-9
references.pmid: 12730500
references.citation: J Virol. 2007 Feb;81(4):1848-57
references.pmid: 17151094
references.citation: J Virol. 2007 Sep;81(18):9812-24
references.pmid: 17596301
references.citation: J Virol. 2005 Feb;79(3):1595-604
references.pmid: 15650185
references.citation: J Virol. 2005 Dec;79(23):14909-22
references.pmid: 16282490
references.citation: J Gen Virol. 2001 Jun;82(Pt 6):1273-1281
references.pmid: 11369870
references.citation: Lancet. 2003 Jul 26;362(9380):263-70
references.pmid: 12892955
references.citation: J Biol Chem. 2007 Nov 2;282(44):32208-21
references.pmid: 17761676
references.citation: Virology. 2002 Apr 25;296(1):177-89
references.pmid: 12036329
references.citation: J Virol. 2007 Oct;81(20):11054-68
references.pmid: 17686858
references.citation: J Virol. 1998 May;72(5):4508-14
references.pmid: 9557750
references.citation: N Engl J Med. 2003 May 15;348(20):1953-66
references.pmid: 12690092
references.citation: Virus Res. 2008 Apr;133(1):20-32
references.pmid: 17499378
references.citation: Virology. 2007 Apr 25;361(1):18-26
references.pmid: 17316733
references.citation: J Virol. 2002 May;76(9):4655-61
references.pmid: 11932433
references.citation: Int J Mol Med. 2005 Feb;15(2):323-7
references.pmid: 15647850
references.citation: J Virol. 2006 Jun;80(11):5168-78
references.pmid: 16698997
references.citation: J Mol Biol. 2003 Aug 29;331(5):991-1004
references.pmid: 12927536
references.citation: J Virol. 2007 Mar;81(6):2554-63
references.pmid: 17182678
references.citation: Science. 2003 Oct 10;302(5643):276-8
references.pmid: 12958366
references.citation: Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1091-105
references.pmid: 15306395
references.citation: Science. 2004 Mar 12;303(5664):1666-9
references.pmid: 14752165
references.citation: Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21
references.pmid: 10805807
references.citation: J Virol. 2002 Nov;76(21):11065-78
references.pmid: 12368349
references.citation: J Virol. 2008 Oct;82(19):9477-91
references.pmid: 18632859
references.citation: J Virol. 2007 Jan;81(2):718-31
references.pmid: 17079322
references.citation: Virol J. 2006 Mar 29;3:17
references.pmid: 16571117
references.citation: Emerg Infect Dis. 2005 Jan;11(1):168-70
references.pmid: 15714661
references.citation: Curr Top Microbiol Immunol. 2005;287:199-227
references.pmid: 15609513
references.citation: Gene. 1991 Dec 15;108(2):193-9
references.pmid: 1660837
references.citation: Lancet. 2003 May 24;361(9371):1767-72
references.pmid: 12781535
references.citation: N Engl J Med. 2003 May 15;348(20):1967-76
references.pmid: 12690091
references.citation: Trends Mol Med. 2003 Aug;9(8):325-7
references.pmid: 12928032
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
references.pmid: 15071187
references.citation: J Infect Dis. 2006 Sep 15;194(6):808-13
references.pmid: 16941348
references.citation: J Virol. 2004 Nov;78(22):12683-8
references.pmid: 15507657
references.citation: J Virol. 2004 Dec;78(24):14043-7
references.pmid: 15564512
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
references.pmid: 14569023
references.citation: Am J Pathol. 2008 Jun;172(6):1625-37
references.pmid: 18467696
references.citation: J Virol. 2007 Jan;81(2):548-57
references.pmid: 17108024
references.citation: J Gen Virol. 2003 Sep;84(Pt 9):2305-2315
references.pmid: 12917450
references.citation: PLoS Pathog. 2007 Aug 10;3(8):e109
references.pmid: 17696607
references.citation: J Clin Virol. 2004 Jul;30(3):211-3
references.pmid: 15135736
references.citation: Science. 1981 Nov 20;214(4523):916-9
references.pmid: 6272391
references.citation: J Virol. 2004 Apr;78(8):3863-71
references.pmid: 15047802
references.citation: J Virol. 2000 Nov;74(22):10600-11
references.pmid: 11044104
references.citation: Cancer Res. 1993 Sep 1;53(17):3976-85
references.pmid: 8358726
references.citation: Cell Mol Life Sci. 2004 Aug;61(16):2100-12
references.pmid: 15316659
references.citation: J Virol. 2007 Jun;81(12):6346-55
references.pmid: 17428862
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5
references.pmid: 16169905
references.citation: J Virol. 2006 Aug;80(15):7481-90
references.pmid: 16840328
references.citation: J Virol. 1987 Dec;61(12):3809-19
references.pmid: 3479621
references.citation: Rev Sci Tech. 2004 Aug;23(2):643-60
references.pmid: 15702725
references.citation: J Virol. 2005 Feb;79(4):2001-9
references.pmid: 15681402
references.citation: J Virol. 2006 Apr;80(7):3670-4
references.pmid: 16537637
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94
references.pmid: 11027311
references.citation: Nucleic Acids Res. 1984 Jun 25;12(12):5123-41
references.pmid: 6330698
references.citation: Virology. 1995 Oct 1;212(2):622-31
references.pmid: 7571432
references.citation: J Virol. 2005 Jan;79(1):503-11
references.pmid: 15596843
references.citation: N Engl J Med. 2003 Dec 18;349(25):2431-41
references.pmid: 14681510
references.citation: PLoS Pathog. 2008 May 02;4(5):e1000054
references.pmid: 18451981
references.citation: J Virol. 2006 Nov;80(21):10900-6
references.pmid: 16928748
references.citation: Proc Natl Acad Sci U S A. 1986 Apr;83(8):2330-4
references.pmid: 3010307
references.citation: J Virol. 2005 Jun;79(11):7095-103
references.pmid: 15890949
references.citation: Adv Exp Med Biol. 2006;581:149-52
references.pmid: 17037522
references.citation: Science. 2005 Oct 28;310(5748):676-9
references.pmid: 16195424